Breast milk may have potential protective effects against SARS-CoV-2, say researchers
The COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.
Jan 29, 2024
0
39
MeSH tree: D23.050.865.450.500.750
The COVID-19 pandemic was an especially harrowing time for pregnant people and new parents.
Jan 29, 2024
0
39
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.
Jan 12, 2024
0
77
Children and adolescents who received one of the main COVID-19 vaccines were significantly protected from the illness and showed no increased signs of cardiac complications compared to young people who were not vaccinated, ...
Jan 8, 2024
0
83
mRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived, many of us are now familiar with it thanks to ...
Dec 19, 2023
0
55
Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.
Dec 12, 2023
0
80
A new Northwestern University study—led by Bernard Black of Northwestern's Pritzker School of Law and Kellogg School of Management—suggests that the U.S. could have saved many lives by authorizing a COVID-19 booster dose ...
Dec 5, 2023
0
71
Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full dose with fewer side effects, according to a new study.
Nov 24, 2023
0
75
The effectiveness of mRNA vaccines in reducing disease severity and hospitalization from COVID-19 is well established. Now, new research from the University of Wisconsin School of Veterinary Medicine advances our understanding ...
Nov 6, 2023
0
79
Pfizer reported Tuesday a loss following a sharp fall in the sales of its COVID-19 vaccine and therapeutic from pandemic peaks.
Oct 31, 2023
0
88
Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue ...
Oct 18, 2023
0
96